Showing results (31-40 of 44) with videos related to

Sort By:
Pageof 5
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 6, 2014
Potential mechanisms for thrombocytopenia development with trastuzumab emtansine (T-DM1)Hirdesh Uppal, Estelle Doudement, Kaushiki Mahapatra, et al.
The Journal of Biological Chemistry|October 23, 2015
Evaluating the Use of Antibody Variable Region (Fv) Charge as a Risk Assessment Tool for Predicting Typical Cynomolgus Monkey PharmacokineticsDaniela Bumbaca Yadav, Vikas K Sharma, Charles Andrew Boswell, et al.
British Journal of Pharmacology|July 5, 2019
Evaluation and use of an anti-cynomolgus monkey CD79b surrogate antibody-drug conjugate to enable clinical development of polatuzumab vedotinDongwei Li, Donna Lee, Randall C Dere, et al.
Frontiers in Immunology|February 25, 2026
Unlocking binding properties of single-domain antibodies targeting the polymeric immunoglobulin receptor to enhance mucosal enrichment of IgG against respiratory syncytial virusJia Liu, Jiwon Jung, Siqun Zhou, et al.
Journal of Medicinal Chemistry|October 18, 2013
Enhanced tumor retention of a radiohalogen label for site-specific modification of antibodiesC Andrew Boswell, Jan Marik, Michael J Elowson, et al.
Bioconjugate Chemistry|September 15, 2011
Impact of drug conjugation on pharmacokinetics and tissue distribution of anti-STEAP1 antibody-drug conjugates in ratsC Andrew Boswell, Eduardo E Mundo, Crystal Zhang, et al.
Nature Communications|May 3, 2025
Leveraging neonatal Fc receptor (FcRn) to enhance antibody transport across the blood brain barrierJulien Lafrance-Vanasse, Shraddha S Sadekar, Yanli Yang, et al.
Neuron|December 22, 2015
Discovery of Novel Blood-Brain Barrier Targets to Enhance Brain Uptake of Therapeutic AntibodiesY Joy Yu Zuchero, Xiaocheng Chen, Nga Bien-Ly, et al.
Science Translational Medicine|November 8, 2014
Therapeutic bispecific antibodies cross the blood-brain barrier in nonhuman primatesY Joy Yu, Jasvinder K Atwal, Yin Zhang, et al.
Cell Reports|August 1, 2016
Antibody-Mediated Targeting of Tau In Vivo Does Not Require Effector Function and Microglial EngagementSeung-Hye Lee, Claire E Le Pichon, Oskar Adolfsson, et al.
Pageof 5